UK markets open in 1 hour 1 minute

MERCK Kommanditgesellschaft auf Aktien (MRK.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
221.00+4.70 (+2.17%)
At close: 05:43PM CET
Full screen
Previous close216.30
Bid221.10 x 6700
Ask221.30 x 11200
Day's range216.70 - 221.80
52-week range126.60 - 226.70
Avg. volume345,203
Market cap96.086B
Beta (5Y monthly)0.45
PE ratio (TTM)35.77
EPS (TTM)6.18
Earnings date03 Mar 2022
Forward dividend & yield1.40 (0.65%)
Ex-dividend date26 Apr 2021
1y target est216.55
  • Reuters

    Merck says making progress on meeting surge in lab gear demand

    Germany's Merck KGaA, which is investing to catch up with ballooning demand for its biotech manufacturing supplies, said the order book in COVID-19 related lab gear was still growing faster than sales but it was getting a better handle on the situation. "We are really very well trained at this time to deal with the supply chain pressures... We have made tremendous progresses, however, our order book is still growing faster than our sales," Chief Executive Belen Garijo told journalists after releasing full quarterly results. "We are getting the situation back on track but it’s going to take a little bit of time to get each and every site up to the necessary targets to be able to fulfil 100% of customer demand," she said, adding that only single-use bioreactor equipment and filters were affected.

  • Zacks

    Nektar (NKTR) Signs Deals With Pfizer, Merck KGaA for NKTR-255

    Nektar (NKTR) signs a collaboration deal with Pfizer and Merck KGaA to develop a combination of its NKTR-255 with the latter's Bavencio for treating urothelial carcinoma.